| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MARS2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | IGSF21 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | CTD-2132N18.3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | LRRC8B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ANKLE1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | NUP62 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TMEM209 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SUMF1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PCDHGB5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | UCHL5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
